Spectrum and Outcome of Noninfectious Aortitis.

Archive ouverte

Ferfar, Yasmina | Morinet, Sarah | Espitia, Olivier | Agard, Christian | Vautier, Mathieu | Comarmond, Cloé | Desbois, Anne Claire | Domont, Fanny | Resche-Rigon, Matthieu | Cacoub, Patrice | Biard, Lucie | Saadoun, David

Edité par CCSD -

International audience. Objective: To assess the spectrum and long-term outcome of patients with noninfectious aortitis.Methods: We performed a retrospective multicenter study of 353 patients (median age at diagnosis was 62 [IQR 46-71] yrs and 242 [68.6%] patients were women) with noninfectious aortitis. Factors associated with vascular complications were assessed in multivariate analysis.Results: We included 136 patients with giant cell arteritis (GCA), 96 with Takayasu arteritis (TA), 73 with clinically isolated aortitis (CIA), and 48 with aortitis secondary to inflammatory diseases (including Behçet disease, relapsing polychondritis, IgG4-related disease, Cogan syndrome, ankylosing spondylitis). After a median follow-up of 52 months, vascular complications were observed in 32.3%, revascularizations in 30% of patients, and death in 7.6%. The 5-year cumulative incidence of vascular complications was 58% (95% CI 41-71), 20% (95% CI 13-29), and 19% (95% CI 11-28) in CIA, GCA, and TA, respectively. In multivariate analysis, male sex (HR 2.10, 95% CI 1.45-3.05, P < 0.0001) and CIA (HR 1.76, 95% CI 1.11-2.81, P = 0.02) were independently associated with vascular complications.Conclusion: Noninfectious aortitis accounts for significant morbidity and mortality. CIA seems to carry the highest rate of vascular complications.

Consulter en ligne

Suggestions

Du même auteur

Long-Term Outcome and Prognosis Factors of Isolated Aortitis.

Archive ouverte | Ferfar, Yasmina | CCSD

International audience. No abstract available

Sarilumab in adults hospitalised with moderate-to-severe COVID-19 pneumonia (CORIMUNO-SARI-1): An open-label randomised controlled trial

Archive ouverte | Mariette, Xavier | CCSD

International audience

Effect of anakinra versus usual care in adults in hospital with COVID-19 and mild-to-moderate pneumonia (CORIMUNO-ANA-1): a randomised controlled trial

Archive ouverte | Tharaux, Pierre-Louis | CCSD

International audience. Background: Patients with COVID-19 pneumonia have an excess of inflammation and increased concentrations of cytokines including interleukin-1 (IL-1). We aimed to determine whether anakinra, a...

Chargement des enrichissements...